Allergic Children’s Parents’ Hesitancy About COVID-19 Vaccination

IF 0.3 Q4 ALLERGY

Astim Allerji Immunoloji Pub Date : 2023-04-07 DOI:10.21911/aai.013

Pınar Yılmazbaş, D. Ozceker

{"title":"Allergic Children’s Parents’ Hesitancy About COVID-19 Vaccination","authors":"Pınar Yılmazbaş, D. Ozceker","doi":"10.21911/aai.013","DOIUrl":null,"url":null,"abstract":"Objective: With the approval of the use of COVID-19 vaccines for children, their administration has started in many countries. However, families have some hesitations about vaccinating their children with the COVID-19 vaccines. The aim of this study was to determine the COVID-19 vaccination rates in allergic children aged 12-19 years and to evaluate contributing factors to vaccine hesitation. Materials and Methods: This cross sectional study was carried out in a Pediatric Allergy Department of a university-affiliated hospital between 15th December 2021 and 15th February 2022. Parents of allergic children who agreed to participate in this study constituted the study population (n=261).Results: Of the 261 children with allergic diseases, 137 (52.4%) had two doses of the COVID-19 vaccine, and 89.3% of the mothers and 92.3% of the fathers had at least two doses of the COVID-19 vaccine. Among children who were not vaccinated (n=124), the leading reason was the novelty of the vaccine, and the second reason was the side effects. The perceived stress scale score of the parents in the vaccinated group was significantly (p <0.05) higher than in the unvaccinated group.Conclusion: Although there is an effective and safe vaccine for children during the pandemic, vaccination rates are not yet at the desired level.","PeriodicalId":42004,"journal":{"name":"Astim Allerji Immunoloji","volume":null,"pages":null},"PeriodicalIF":0.3000,"publicationDate":"2023-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Astim Allerji Immunoloji","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21911/aai.013","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ALLERGY","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: With the approval of the use of COVID-19 vaccines for children, their administration has started in many countries. However, families have some hesitations about vaccinating their children with the COVID-19 vaccines. The aim of this study was to determine the COVID-19 vaccination rates in allergic children aged 12-19 years and to evaluate contributing factors to vaccine hesitation. Materials and Methods: This cross sectional study was carried out in a Pediatric Allergy Department of a university-affiliated hospital between 15th December 2021 and 15th February 2022. Parents of allergic children who agreed to participate in this study constituted the study population (n=261).Results: Of the 261 children with allergic diseases, 137 (52.4%) had two doses of the COVID-19 vaccine, and 89.3% of the mothers and 92.3% of the fathers had at least two doses of the COVID-19 vaccine. Among children who were not vaccinated (n=124), the leading reason was the novelty of the vaccine, and the second reason was the side effects. The perceived stress scale score of the parents in the vaccinated group was significantly (p <0.05) higher than in the unvaccinated group.Conclusion: Although there is an effective and safe vaccine for children during the pandemic, vaccination rates are not yet at the desired level.

查看原文本刊更多论文

过敏儿童家长对COVID-19疫苗接种的犹豫

目的:随着COVID-19儿童疫苗的批准使用，许多国家已开始接种疫苗。然而，一些家庭对给孩子接种COVID-19疫苗有一些犹豫。本研究的目的是确定12-19岁过敏儿童的COVID-19疫苗接种率，并评估疫苗犹豫的影响因素。材料和方法:本横断面研究于2021年12月15日至2022年2月15日在一所大学附属医院的儿科过敏科进行。同意参加本研究的过敏儿童的父母构成研究人群(n=261)。结果:261例过敏性疾病患儿中，有137例(52.4%)接种了2剂新冠肺炎疫苗，89.3%的母亲和92.3%的父亲至少接种了2剂新冠肺炎疫苗。在未接种疫苗的儿童中(n=124)，主要原因是疫苗的新颖性，其次是副作用。接种疫苗组家长感知应激量表得分显著高于未接种疫苗组(p <0.05)。结论:虽然在大流行期间有一种有效和安全的儿童疫苗，但疫苗接种率尚未达到预期水平。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Astim Allerji Immunoloji ALLERGY-

CiteScore

0.80

自引率

0.00%

发文量

期刊介绍： Asthma Allergy Immunology has been published three times a year in April, August and December as the official and periodical journal of the Turkish National Society of Allergy and Clinical Immunology since 2003. All articles published in the journal have been available online since 2003. A peer reviewed system is used in evaluation of the manuscripts submitted to Asthma Allergy Immunology. The official language of the journal is English. The aim of the journal is to present advances in the field of allergic diseases and clinical immunology to the readers. In accordance with this goal, manuscripts in the format of original research, review, case report, articles about clinical and practical applications and editorials, short report and letters to the editor about allergic diseases and clinical immunology are published in the journal. The target reader population of the Asthma Allergy Immunology includes specialists and residents of allergy and clinical immunology, pulmonology, internal medicine, pediatrics, dermatology and otolaryngology as well as physicians working in other fields of medicine interested in allergy and immunological diseases.